Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines
スポンサーリンク
概要
- 論文の詳細を見る
Mesothelioma, a highly aggressive cancer with poor prognosis and refractory to currently available therapies show increasing trends of its incidence in Japan and other developing countries. Although surgery is a gold standard for patients with early mesothelioma, most patients with advanced disease are not suitable for surgical resection and have option of palliative chemotherapy alone. One of the new treatment strategies for mesothelioma, the humanized anti-CD26 monoclonal antibody therapy is under development. CD26, a 110-kDa transmembrane glycoprotein with known dipeptidyl peptidase IV activity, plays a role in tumor development and its expression was reported in various human malignancies. This study determined the preliminary selection criteria for humanized monoclonal anti-CD26 antibody therapy. Eighty-one epithelioid (49 differentiated and 32 less differentiated), 34 sarcomatoid, 19 biphasic mesothelioma and 8 mesothelioma cell lines were immunohistochemically examined using 8 different commercially available anti-CD26 antibodies for membranous and cytoplasmic expression. The cytoplasmic expression of CD26 was observed in all histological types of mesothelioma, while the membranous expression of CD26 was found in 88% of differentiated and 69% of less differentiated epithelioid mesothelioma, and none of sarcomatoid mesothelioma with anti-CD26 antibodies with rabbit polyclonal anti-DPP4 antibody and similar results were also obtained with goat polyclonal anti-DPP4/CD26 antibody. These antibodies absorbed with soluble human CD26 proteins do not show CD26 expression in mesothelioma tissue, suggesting these two antibodies localize true CD26 protein. Seven mesothelioma cell lines, including sarcomatoid types, also showed membranous expression of CD26 in cellblock preparation.CD26 vector transfection to CD26-negative MSTO-211H cells showed membranous expression of CD26 by flow cytometry, but not in tumor developed in NOD/SCID mice with inoculation of CD26 vector transfected MSTO-211H cells. We found that both rab
- Spandidos Publications Ltd.の論文
- 2011-09-05
著者
-
Amatya VJ
広島大学大学院医歯薬学総合研究科病理学
-
Jeet Amatya
広島大学大学院医歯薬学総合研究科病理学
-
AMATYA Vishwa
Department of Pathology, Graduate School of Biomedical Sciences, Hiroshima University
-
Jeet Amatya
Department Of Pathology Graduate School Of Biomedical Sciences Hiroshima University
関連論文
- P-536 上皮型中皮腫と非腫瘍性中皮細胞の鑑別に有用な免疫組織化学的染色の検討(一般演題(ポスター) 胸膜中皮腫2,第48回日本肺癌学会総会号)
- 28.中皮腫における分泌型Wnt阻害蛋白遺伝子のプロモーター領域のメチル化の検討(第46回日本肺癌学会中国・四国支部会)
- Glioblastoma treated with postoperative radio-chemotherapy : Prognostic value of apparent diffusion coefficient at MR imaging
- P-673 上皮型中皮腫と反応性中皮細胞過形成の鑑別診断における抗GLUT-1抗体を用いた免疫組織化学的染色の有用性(悪性中皮腫3,第49回日本肺癌学会総会号)
- P-672 中皮腫における分泌型Wnt阻害蛋白遺伝子のプロモーター領域のメチル化と蛋白発現の検討-第2報(悪性中皮腫3,第49回日本肺癌学会総会号)
- O-97 Caveolin-1, a novel marker, differentiates epithelioid mesothelioma from lung adenocarcinoma
- 19. Caveolin-1 (CAV1) is novel marker of epithelioid mesothelioma (EM) for differentiating it from lung adenocarcinoma (LAC)
- P-317 Gene Expression Analysis of malignant mesothelioma using FFPE samples
- P-212 中皮腫における分泌型Wnt阻害蛋白遺伝子のプロモーター領域のメチル化と蛋白発現の検討(一般演題(ポスター)22 胸膜中皮腫1,第48回日本肺癌学会総会号)
- Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast
- Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma
- Loss of expression of E-cadherin and β-catenin is associated with progression of pulmonary adenocarcinoma
- Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation
- Inactivation of the p16 gene by hypermethylation and loss of heterozygosity in adenocarcinoma of the lung
- Myxopapillary ependymoma with anaplastic features
- Case of clear cell ependymoma of medulla oblongata : Clinicopathological and immunohistochemical study with literature review
- Idiopathic granulomatous meningoencephalitis presenting as an intracranial tumor
- Meningioma in mature cystic teratoma of the ovary
- Reg IV is an independent prognostic factor for relapse in patients with clinically localized prostate cancer
- Letter to the Editor
- Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry
- Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas : Comparative study with 11 pilocytic astrocytomas
- 2.良性、異型、退形成性髄膜腫におけるKi-67 (MIB-1), p53蛋白、p21^, and p27^の発現に関する免疫組織化学的検討(学位論文抄録)(第467回広島大学医学集談会(平成14年11月7日))
- Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines
- 顔面神経麻痺で発症した錐体骨malignant fibrous histiocytomaの1例
- Evaluation of Apoptosis and Immunohistochemical Expression of the Apoptosis-related Proteins in Mesothelioma
- 側頭葉に発生したpapillary glioneuronal tumorの1例
- 顔面神経麻痺で発症した錐体骨 malignant fibrous histiocytoma の1例